40 related articles for article (PubMed ID: 22415095)
1. Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood-Brain Barrier Models.
Kirchner J; Völker E; Shityakov S; Saji S; Förster CY
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542355
[TBL] [Abstract][Full Text] [Related]
2. Functional estrogen receptors in the mitochondria of breast cancer cells.
Pedram A; Razandi M; Wallace DC; Levin ER
Mol Biol Cell; 2006 May; 17(5):2125-37. PubMed ID: 16495339
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor beta as a mitochondrial vulnerability factor.
Yang SH; Sarkar SN; Liu R; Perez EJ; Wang X; Wen Y; Yan LJ; Simpkins JW
J Biol Chem; 2009 Apr; 284(14):9540-8. PubMed ID: 19189968
[TBL] [Abstract][Full Text] [Related]
4. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.
Nadal-Serrano M; Sastre-Serra J; Pons DG; Miró AM; Oliver J; Roca P
J Cell Biochem; 2012 Oct; 113(10):3178-85. PubMed ID: 22615145
[TBL] [Abstract][Full Text] [Related]
5. 17-β Estradiol up-regulates energy metabolic pathways, cellular proliferation and tumor invasiveness in ER+ breast cancer spheroids.
Pacheco-Velázquez SC; Ortega-Mejía II; Vargas-Navarro JL; Padilla-Flores JA; Robledo-Cadena DX; Tapia-Martínez G; Peñalosa-Castro I; Aguilar-Ponce JL; Granados-Rivas JC; Moreno-Sánchez R; Rodríguez-Enríquez S
Front Oncol; 2022; 12():1018137. PubMed ID: 36419896
[TBL] [Abstract][Full Text] [Related]
6. Role of Mitochondrial Stress Response in Cancer Progression.
Lee YG; Park DH; Chae YC
Cells; 2022 Feb; 11(5):. PubMed ID: 35269393
[TBL] [Abstract][Full Text] [Related]
7. Estrogen Receptor Beta (ERβ) Maintains Mitochondrial Network Regulating Invasiveness in an Obesity-Related Inflammation Condition in Breast Cancer.
Martinez-Bernabe T; Sastre-Serra J; Ciobu N; Oliver J; Pons DG; Roca P
Antioxidants (Basel); 2021 Aug; 10(9):. PubMed ID: 34573003
[TBL] [Abstract][Full Text] [Related]
8. Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells.
Radde BN; Ivanova MM; Mai HX; Alizadeh-Rad N; Piell K; Van Hoose P; Cole MP; Muluhngwi P; Kalbfleisch TS; Rouchka EC; Hill BG; Klinge CM
Exp Cell Res; 2016 Sep; 347(1):222-231. PubMed ID: 27515002
[TBL] [Abstract][Full Text] [Related]
9. Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway.
Yang H; Yang R; Liu H; Ren Z; Kong F; Li D; Ma X
Onco Targets Ther; 2016; 9():3963-73. PubMed ID: 27418839
[TBL] [Abstract][Full Text] [Related]
10. Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement.
Morgan MM; Johnson BP; Livingston MK; Schuler LA; Alarid ET; Sung KE; Beebe DJ
Pharmacol Ther; 2016 Sep; 165():79-92. PubMed ID: 27218886
[TBL] [Abstract][Full Text] [Related]
11. The complex nature of oestrogen signalling in breast cancer: enemy or ally?
Lipovka Y; Konhilas JP
Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27160081
[TBL] [Abstract][Full Text] [Related]
12. Activation of ERα signaling differentially modulates IFN-γ induced HLA-class II expression in breast cancer cells.
Mostafa AA; Codner D; Hirasawa K; Komatsu Y; Young MN; Steimle V; Drover S
PLoS One; 2014; 9(1):e87377. PubMed ID: 24475282
[TBL] [Abstract][Full Text] [Related]
13. The exposure of breast cancer cells to fulvestrant and tamoxifen modulates cell migration differently.
Lymperatou D; Giannopoulou E; Koutras AK; Kalofonos HP
Biomed Res Int; 2013; 2013():147514. PubMed ID: 23936773
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta interacts and colocalizes with HADHB in mitochondria.
Zhou Z; Zhou J; Du Y
Biochem Biophys Res Commun; 2012 Oct; 427(2):305-8. PubMed ID: 23000159
[TBL] [Abstract][Full Text] [Related]
15. The effects of 17β-estradiol on mitochondrial biogenesis and function in breast cancer cell lines are dependent on the ERα/ERβ ratio.
Sastre-Serra J; Nadal-Serrano M; Pons DG; Valle A; Oliver J; Roca P
Cell Physiol Biochem; 2012; 29(1-2):261-8. PubMed ID: 22415095
[TBL] [Abstract][Full Text] [Related]
16. The over-expression of ERbeta modifies estradiol effects on mitochondrial dynamics in breast cancer cell line.
Sastre-Serra J; Nadal-Serrano M; Pons DG; Roca P; Oliver J
Int J Biochem Cell Biol; 2013 Jul; 45(7):1509-15. PubMed ID: 23618876
[TBL] [Abstract][Full Text] [Related]
17. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.
Nadal-Serrano M; Pons DG; Sastre-Serra J; Blanquer-Rosselló Mdel M; Roca P; Oliver J
Int J Biochem Cell Biol; 2013 Sep; 45(9):2045-51. PubMed ID: 23871935
[TBL] [Abstract][Full Text] [Related]
18. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P
J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
